Yimaikang Tablets
Function and Efficacy
The results of preclinical animal experiments showed that this product can reduce the content of malondialdehyde (MDA) in rabbits with chronic high intraocular pressure, increase the activity of superoxide dismutase (SOD), and reduce the permeability of retinal blood vessels; and improve the grayscale of retinal ganglion cells with high cytochrome oxidase activity and the density of active ganglion cells in rats with acute high intraocular pressure.
Ingredients
The chemical components of Erigeron breviscapus extract are mainly flavonoids (main component), lactones, amino acids, polysaccharides, such as pyrofuconic acid (P,romeconic acid) and its glucoside, scutellarin (Scutellarin), apigenin (Api,enin), and luteolin (Luleolin).
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Flavonoid adsorption resinIngredients |
It reduces the content of malondialdehyde (MDA) in rabbits with chronic intraocular hypertension, increases the activity of superoxide dismutase (SOD), and reduces the permeability of retinal blood vessels; it improves the grayscale of retinal ganglion cells and the density of active ganglion cells with high cytochrome oxidase activity in rats with acute intraocular hypertension. More |
83162-84-9 | 0 | |
| L-tert-LeucineIngredients |
It reduces the content of malondialdehyde (MDA) in rabbits with chronic intraocular hypertension, increases the activity of superoxide dismutase (SOD), and reduces the permeability of retinal blood vessels; it improves the grayscale of retinal ganglion cells and the density of active ganglion cells with high cytochrome oxidase activity in rats with acute intraocular hypertension. More |
20859-02-3 | 0 | |
| IRISH MOSSIngredients |
It reduces the content of malondialdehyde (MDA) in rabbits with chronic intraocular hypertension, increases the activity of superoxide dismutase (SOD), and reduces the permeability of retinal blood vessels; it improves the grayscale of retinal ganglion cells and the density of active ganglion cells with high cytochrome oxidase activity in rats with acute intraocular hypertension. More |
9062-07-1 | 0 |
Appearance
This product is a sugar-coated tablet, which appears brown after removing the sugar coating; it tastes slightly bitter.
Usage and Dosage
Oral administration: 2 tablets at a time, three times a day.
Adverse Reactions
A very small number of patients experience dizziness, gastrointestinal discomfort and other reactions after taking the medicine, which disappear after reducing or stopping the dose.
Precautions
Not yet clear.
Drug Interactions
Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.
Storage
Sealed and protected from light.
Packaging Specification
Each tablet weighs 0.31g (containing 40mg total flavonoids)
Validity Period
24 months
Manufacturer
Kunming Sinoway NATURAL Pharmaceuticals Co., Ltd.
-
Founded in:
1998-06-24 -
Address:
No. 160, Linxi Road, Information Industry Base, Kunming Economic and Technological Development Zone, Yunnan Province -
Tax NO.:
91530100709706713D -
Registered Funds:
44.257068 million yuan -
Website:
-
Email: